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AbsTrACT
background Understanding how pathogen genetic 
factors contribute to pathology in TB could enable 
tailored treatments to the most pathogenic and 
infectious strains. new strategies are needed to 
control drug- resistant TB, which requires longer and 
costlier treatment. We hypothesised that the severity 
of radiological pathology on the chest radiograph 
in TB disease was associated with variants arising 
independently, multiple times (homoplasies) in the 
Mycobacterium tuberculosis genome.
Methods We performed whole genome sequencing 
(illumina hiseq2000 platform) on M. tuberculosis 
isolates from 103 patients with drug- resistant TB in lima 
between 2010 and 2013. Variables including age, sex, 
hiV status, previous TB disease and the percentage of 
lung involvement on the pretreatment chest radiograph 
were collected from health posts of the national TB 
programme. genomic variants were identified using 
standard pipelines.
results Two mutations were significantly associated 
with more widespread radiological pathology in 
a multivariable regression model controlling for 
confounding variables (rv2828c.141, rr 1.3, 95% ci 
1.21 to 1.39, p<0.01; rpoc.1040 95% ci 1.77 to 2.16, 
rr 1.9, p<0.01). The rpoB.450 mutation was associated 
with less extensive radiological pathology (rr 0.81, 
95% ci 0.69 to 0.94, p=0.03), suggestive of a bacterial 
fitness cost for this mutation in vivo. Patients with a 
previous episode of TB disease and those between 10 
and 30 years of age also had significantly increased 
radiological pathology.
Conclusions This study is the first to compare the M. 
tuberculosis genome to radiological pathology on the 
chest radiograph. We identified two variants significantly 
positively associated with more widespread radiological 
pathology and one with reduced pathology. Prospective 
studies are warranted to determine whether mutations 
associated with increased pathology also predict the 
spread of drug- resistant TB.
InTroduCTIon
Pathology in TB disease depends on host, pathogen 
and environmental factors. Understanding to what 
extent pathogen genetic factors contribute to the 
variability in pulmonary pathology due to Myco-
bacterium tuberculosis could allow those patients 
that harbour the most pathogenic and thereby 
infectious organisms1 2 to be identified for enhanced 
treatments, transmission prevention measures and 
contact tracing. Multidrug- resistant tuberculosis 
(MDRTB) treatment outcomes are worse, medica-
tions are more toxic and the cost of treatment is 10 
times greater than drug- susceptible TB.3 This makes 
prevention of new cases of MDRTB particularly 
important. Although there is now a greater under-
standing of which polymorphisms are associated 
with drug resistance in TB, relatively little is known 
about the consequences of the genetic makeup of 
the pathogen on disease severity and progression in 
vivo. So far, no studies have examined the associa-
tion of the M. tuberculosis pathogen genome with 
radiologically quantified pathology on the chest 
radiograph.
Many studies have implicated the influence of M. 
tuberculosis lineage with TB pathogenesis in labora-
tory animals; however, these studies are limited by 
comparison to laboratory strains and typically lack 
information about whole genome variability.4–6 It is 
well established that there is a fitness cost arising 
from some rifampicin resistance conferring muta-
tions in some drug- resistant strains in vitro,7 and 
drug- resistant strains have been shown to cause less 
pathology in guinea pigs8 than controls. However, 
Comas et al demonstrated that this fitness cost in 
M. tuberculosis when measured in vitro by compet-
itive fitness assays can be mitigated by compensa-
tory mutations in the rpoA and rpoC genes.9 The 
Key messages
What is the key question?
 ► Is there an association between bacterial 
genotype and pathology in drug- resistant TB?
What is the bottom line?
 ► This study demonstrates that polymorphisms 
in Rv2828c and rpoC are independently 
associated with more widespread pathology on 
the pretreatment chest radiograph of patients 
with drug- resistant TB.
Why read on?
 ► As the first study to compare the 
Mycobacterium tuberculosis genome to 
radiological pathology on the chest radiograph, 
it improves our understanding of how pathogen 
genetic factors contribute to pathology in TB, 
which could enable tailored treatments to the 
most pathogenic and infectious strains.
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Table 1 Clinical, demographic and pathogen data for the 103 
isolates included in the study
Variable no. (%*†)
No. of patients 103
Male gender (%) 71 (69)
Age
  10–19 21 (20)
  20–29 46 (45)
  30–39 13 (13)
  40–49 11 (11)
  50–59 7 (7)
  60–69 2 (2)
  70–79 2 (2)
  Missing 1 (1)
HIV positive 5 (5)
Radiological pathology % of lung involved (median/IQR) 30 (15–50)
Drug susceptibility status
  Mono- resistant 12 (12)
  MDR 91 (88)
  Previous tuberculosis disease 30 (29)
Lineage
  Lineage 2.2.1 7 (7)
  Lineage 4 7 (7)
  Lineage 4.1 1 (1)
  Lineage 4.1.1 5 (5)
  Lineage 4.1.1.3 4 (4)
  Lineage 4.1.2.1 10 (10)
  Lineage 4.3.2 4 (4)
  Lineage 4.3.3 43 (42)
  Lineage 4.3.4.1 4 (4)
  Lineage 4.3.4.2 17 (16)
  Lineage 4.8 1 (1)
*% total 101 due to rounding.
†No missing data unless stated.
MDR, multidrug resistant .
heterogeneity in the fitness cost of drug resistance mutations is 
also key to the future predictions of MDRTB spread.10 11
Convergent evolutionary (homoplastic) mutations emerging 
recurrently and independently at the same locus in multiple 
clades of the phylogeny form a subset of mutations likely to 
have been affected by strong directional natural selection. These 
homoplastic mutations represent excellent candidate muta-
tions for polymorphisms involved in antimicrobial resistance, 
immune evasion and virulence12 13 and may influence radiolog-
ical pathology and outcome.
Work by Ralph and colleagues14 has demonstrated that assess-
ment of the degree of pulmonary parenchymal involvement on 
the chest radiograph can be reliably reproduced by independent 
observers with a high agreement between observers and that 
this is predictive of the sputum smear result at 2 months. We 
hypothesised that some convergent evolutionary polymorphisms 
could be significantly associated with lung pathology as quanti-
fied by the extent of pulmonary parenchymal involvement on 
the pretreatment diagnostic chest radiograph. In order to test 
this hypothesis, we performed whole genome sequencing on 103 
TB patients with drug- resistant disease in Lima who had a chest 
radiograph performed before the start of treatment.
MATerIAls And MeThods
Field methods, culture techniques and sample selection
Collection of clinical and demographic variables, sampling of 
sputa, culture and DNA extraction were undertaken as previ-
ously described.15 Briefly, samples with available pretreatment 
chest radiographs were selected from a prospective cohort 
study16 undertaken in the regions of Callao and Lima South 
between 2010 and 2013. Demographic data such as age and 
sex were collected from the clinical record at the health post. 
Previous TB disease was defined as any previous episode of 
clinically diagnosed and treated TB disease prior to the present 
episode. A pretreatment chest radiograph was defined as a 
radiograph taken before the onset of treatment for the current 
episode of TB disease at the same time as the initial diagnostic 
sampling. Testing for HIV was undertaken for all patients, and 
this result was confirmed from the clinical record. A bad treat-
ment outcome was defined as those that died during treatment 
or had a bacteriological failure of treatment, while a good treat-
ment outcome was defined as treatment completion or success 
as per the WHO guidelines.17 Those that transferred treatment 
outside the study area or those that abandoned treatment were 
regarded as unknown outcomes.
Sputum samples from all patients were transported to the 
regional reference laboratories and processed both on liquid 
(MODS) and solid Ogawa media. An aliquot of each posi-
tive culture was subcultured at Universidad Peruana Cayetano 
Heredia and DNA was extracted.15 All samples were retested 
and had drug susceptibility profiles confirmed at the national 
reference laboratory using the proportions method on agar.
reading of chest radiographs and quantification of pathology
Chest radiographs included in the analysis were all correctly 
labelled, posteroanterior, baseline pretreatment films. Poor 
quality radiographs were excluded if they were over or under 
penetrated, over rotated or with inadequate field of view. Chest 
radiographs were read independently and prior to data anal-
ysis as described14 18 by two experienced clinicians blinded to 
the sequencing data and specialised in managing TB. The total 
percentage of the lung opacified with pathology was used as the 
pathology score outcome as previous studies have demonstrated 
that this is the only reliably reproducible indicator between 
observers.14 Briefly, the lungs were divided into six equally sized 
zones and the percentage of opacity in each zone and overall 
was estimated to the nearest 5%.18 Readings from the two 
observers were compared to quantify the degree of correlation 
between observers and an average of the two readings was used 
for the analysis. In addition to Spearman’s rank correlation, a 
Bland- Altman plot was used to compare the agreement between 
reviewers.
Genome sequence quality control
We prepared Illumina sequencing libraries with a 450 bp insert 
size, using the manufacturer’s protocols, and then undertook 
sequencing on an Illumina HiSeq2000 with paired- end reads of 
length of 100 bp. We multiplexed 96 samples per lane to attain 
an average depth of coverage of ~97- fold. We confirmed the 
species in the short reads using Kraken19 and then assembled the 
paired- end sequence reads with an improved assembly pipeline,20 
based on Velvet.21 A list of isolates and their accession numbers 
in the European Nucleotide Archive is provided in online 
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Figure 1 Study phylogeny with branches coloured by sublineage as defined by Coll et al. Clinical outcome following treatment is displayed (bad 
outcome: black dots, good outcome: grey dots on the tips of the tree) in a ring surrounding the phylogeny with the pathology on chest radiograph (% 
of lung with disease) represented by a circle of varying size according to the extent of pathology.
supplementary file 1 (project number: ERP004677). Following 
this, short reads were mapped to the corrected H37Rv reference 
genome available from Casali et al22  genome. cshlp. org/ content/ 
suppl/ 2012/ 02/ 01/ gr. 128678. 111. DC1/ 1_ H37RvQM_ embl. txt. 
In doing so, we employed SMALT V.0.7.4 ( www. sanger. ac. uk/ 
science/ tools/ smalt- 0) using maximum and minimum insert sizes 
of 1000 and 50, respectively. To annotate single nucleotide poly-
morphisms (SNPs), we used SAMtools mpileup23 and BCFtools, 
as described by Harris et al.24 We included SNPs that were 
covered by at least two forward and two reverse short paired- end 
reads.25 A minimum base call quality of 50 and a minimum root 
mean squared mapping quality of 30 to call a SNP were used. 
Furthermore, the SNPs at sites with heterogeneous mapping 
where less than 75% of reads at that site covered the SNP were 
excluded from the analysis.24 We obtained the multiple align-
ment by generating pseudosequences, after ignoring small indels. 
Any site with >5% non- calls was excluded from the analysis, 
and an arbitrary minimum SNP prevalence threshold of 3% 
(3/103) and a homoplasy count of a minimum of three inde-
pendent occurrences across the phylogenetic tree were chosen 
to avoid spurious comparison of low prevalence mutant strains.
Phylogenetic analysis
A maximum likelihood tree was constructed with concatenated 
SNPs from the whole genome sequence data using R software 
(R Foundation for Statistical Computing, Vienna, Austria 2011, 
www. R- project. org) with the PHANGORN package.26 Clades 
were named according to the latest SNP- based bar code.27
Identification of convergent evolutionary variants
Variants were identified using phyC software12 to determine the 
number of independent occasions in which an ancestral base was 
different from the descendent base at any given site in the tree.
sample size and model construction
As no previous study had been undertaken to provide an esti-
mate of the expected effect size, formal power calculation was 
not performed. The study aim to recruit more than 100 patients 
was therefore based on pragmatic and systematic considerations. 
The extent of radiological pathology was Poisson distributed; 
therefore, a Poisson model was constructed using this variable as 
the dependent variable. Univariate analysis was first undertaken 
for each polymorphism. Polymorphisms with a p value of <0.05 
on univariate analysis were selected for inclusion in a multi-
variable model together with confounding variables. The set of 
confounding variables that were included in the multivariable 
model was defined a priori. These included sex, age, previous 
TB disease, drug resistance status (mono- resistant or multidrug- 
resistant) and lineage. Multivariable Poisson regression was used 
to calculate the p values having corrected for confounding vari-
ables. The R package ‘stats’ was then used to plot the predicted 
pathology having accounted for other confounding variables in 
the multivariable model. All p values were Bonferroni corrected. 
Missing data were omitted and managed using the default ‘ na. 
omit’ setting under the glm function in R. Following reviewers’ 
comments, we performed additional population level correction 
3Grandjean L, et al. Thorax 2020;0:1–8. doi:10.1136/thoraxjnl-2019-213281
Tuberculosis
Figure 2 The distribution of homoplastic polymorphisms identified in the study. A, adenine, G, guanine, C, cytosine, T, thymine, N, unknown (no call).
Table 2 Homoplastic mutations identified in the dataset
reference position Gene Mutation homoplasies (n) no. (Prevalence) reference base Mutant base
761160 rpoB Ser450Leu 13 54 (52%) C T
2155176 katG Ser315Thr
Ser315Asn
10 71 (69%) C G/T
4247436 embB Met306Val 9 13 (13%) A G
1473254 rrs A1401G rRNA gene 5 5 (5%) A G
3135920 Rv2828c Thr141Arg 4 34 (33%) G C
4247438 embB Met306Ile 4 16 (16%) G A/C/T
766493 rpoC Pro1040Arg
Pro1040Leu
3 3 (3%) C G/T
761114 rpoB Asp435Tyr 3 3 (3%) G T
761144 rpoB His445Asp
His445Tyr
3 9 (9%) C G/T
2123153 lldD2 Val3Ile 3 13 (13%) C T
using principal components28 to account for the effect of lineage 
on the association between the homoplastic polymorphisms and 
radiological pathology. We also performed a subanalysis of our 
principal findings with and without the inclusion of patients 
with previous TB disease as a variable.
resulTs
A total of 103 different patients had radiological, clinical, demo-
graphic and pathogen data available for analysis (table 1). The 
proportion of patients with MDRTB was 88% (91/103) and 
5% (5/103) were HIV positive. The predominant sublineage 
was lineage 4.3.3 (41%, 43/103) of the Euro- American lineage 
(Lineage 4). As a likely consequence of Chinese immigration to 
Peru in the mid-19th century to work on the railways and guano 
farms, 7% (7/103) of strains were from the Beijing family (table 1, 
figure 1, online supplementary figure 2). Evaluation of the 
extent of radiological pathology by two independent observers 
was significantly positively correlated using the Spearman rank 
correlation coefficient between observer pathology scores 
(Spearman ρ=0.66, 95% CI 0.53 to 0.76, p<0.001) (online 
supplementary figure 1). The mean difference in pathology 
scores between observers in the Bland- Altman analysis was 
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Figure 3 Distribution of radiograph pathology as a function of epidemiological and pathogen genetic variables; (A) previous episode of TB, rate 
ratio 1.2, p=<0.01; (B) age range 10–30 versus other ages, rate ratio 1.2, p<0.01; (C) gender, rate ratio 1.13, p=0.29; (D) rpoB 450; Rr 0.8, p=0.03; (E) 
rpoC.1040, Rr 1.97, p<0.01; (F) Rv2828c.141, Rr 1.3, p<0.01.
4.7%, while the upper limit of agreement was 43.1% (95% 
CI 36.7 to 43.1) and the lower limit −32.9% (95% CI −26.5 
to −39.4). Pathology appeared evenly distributed by sublin-
eage before considering confounding variables and there were 
eight bad outcomes (failed treatment or died during treatment) 
(8/103) according to the WHO definitions (figure 1). The distri-
bution of homoplastic variants across the phylogenetic tree is 
shown in figure 2; the most frequently observed homoplastic 
mutation was the rpoB Ser450Leu mutation, which occurred 
independently 13 times with a prevalence of 54% in the study 
population (figure 2, table 2).
Clinical and demographic variables associated with chest 
radiograph pathology
A previous episode of TB disease was associated with more 
extensive pathology on the chest radiograph (RR 1.2, p<0.01, 
95% CI 1.10 to 1.28; figure 3A). Those aged between 30 and 39 
had less severe disease than those between 10 and 19 years of age 
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Table 3 Variables in the multivariable predictive regression model of radiological pathology in multidrug- resistant tuberculosis with rate ratios and 
their associated lower and upper 95% CI, SE and p values
Variable rate ratio upper CI lower CI se P value*
Mutation
katG.315 1.14 1.28 1.01 0.07 1.00
rpoB.450 0.81 0.94 0.69 0.06 0.03
rpoC.1040 1.97 2.16 1.77 0.10 <0.01
rpoB.435 1.21 1.40 1.01 0.10 1.00
Rv2828c.141 1.30 1.39 1.21 0.04 <0.01
embB.306 0.86 0.97 0.74 0.06 0.27
rpoB.445 1.09 1.25 0.93 0.08 1.00
Male gender 1.13 1.23 1.04 0.05 0.29
HIV positive 0.84 1.02 0.66 0.09 1.00
Age 10–19 Comparison Comparison Comparison Comparison Comparison
Age 20–29 0.97 1.08 0.87 0.05 1.00
Age 30–39 0.66 0.82 0.50 0.08 <0.01
Age 40–49 0.93 1.08 0.78 0.08 1.00
Age 50–59 1.20 1.37 1.02 0.09 1.00
Age 60–69 0.71 1.04 0.38 0.17 1.00
Age 70–79 0.43 0.79 0.07 0.18 <0.01
MDR Comparison Comparison Comparison Comparison Comparison
Mono- resistant 0.86 0.99 0.72 0.07 0.75
Previous TB 1.19 1.28 1.10 0.05 <0.01
Lineage 2 Comparison Comparison Comparison Comparison Comparison
Lineage 4 1.28 1.49 1.08 0.10 0.48
Lineage 4.1.1 1.32 1.54 1.10 0.11 0.33
Lineage 4.1.1.3 1.06 1.34 0.78 0.14 1.00
Lineage 4.1.2.1 1.34 1.52 1.16 0.09 0.05
Lineage 4.3.2 1.15 1.40 0.89 0.13 1.00
Lineage 4.3.3 1.02 1.18 0.87 0.08 1.00
Lineage 4.3.4.1 0.61 0.89 0.33 0.14 0.02
Lineage 4.3.4.2 1.26 1.43 1.08 0.09 0.27
Lineage 4.8 0.98 1.39 0.57 0.21 1.00
*Bonferroni- corrected p value.
(RR 0.66, p<0.01, 95% CI 0.50 to 0.82). When age as a variable 
in the multivariable model was trichotomised into those less than 
30, between 30 and 50 years old and those greater than 50 years 
of age, those less than 30 years of age were shown to have more 
severe disease than those between 30 and 50 years of age (RR 
1.3, p<0.01, 95% CI 1.17 to 1.38, figure 3B). There was no 
significant difference in pathology observed by sex (figure 3C). 
HIV infection was not statistically associated with more severe 
disease.
Association between homoplastic polymorphisms and chest 
radiograph pathology
We detected 10 homoplastic polymorphisms in 103 strains. 
Other than the rrs A1401G mutation that occurred in an rRNA 
gene, all homoplastic polymorphisms detected in the dataset 
were non- synonymous (amino acid changing). Seven homo-
plastic polymorphisms were associated with the extent of lung 
pathology with a p value<0.05 on univariate analysis and 
these were included in the multivariable regression together 
with clinical and sociodemographic confounding variables. 
Three mutations were significantly associated with radiolog-
ical pathology after controlling for confounding variables and 
Bonferroni correction (table 3).
The Pro1040Lys mutation in rpoC had the greatest effect 
size on radiological pathology with a rate ratio of 1.9 (95% 
CI 1.77 to 2.16, p<0.01; figure 3E). Patients that harboured 
a strain with this mutation had a mean pathology score almost 
twice that of those without the mutation. This was independent 
of other confounding variables, although, the prevalence of the 
rpoC.1040 mutation was only at a frequency of 3%, limiting 
its influence at the population level. In contrast, the Rv2828c 
Thr141Arg mutation occurred in 34% of the population at a 
rate ratio of 1.3 (95% CI 1.21 to 1.39, figure 3F), meaning that 
those with disease caused by a strain with the mutation had 
30% more likely to have more widespread pathology than those 
without. The most prevalent homoplastic mutation rpoB S450L 
(known to be associated with rifampicin resistance) was associ-
ated with decreased pathology (rate ratio 0.8, p=0.03, 95% CI 
0.69 to 0.94; figure 3D). However, the protective association 
of this rpoB.450 polymorphism on radiological pathology 
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was not statistically significant when additional correction for 
population structure with principal component analysis (PCA) 
was performed, demonstrating that the association may be 
confounded by lineage. Neither did this polymorphism remains 
statistically significantly protective of pathology when a subanal-
ysis was performed on only TB naïve patients, suggesting that 
this association was influenced by prior disease status.
dIsCussIon
This is the first published study to compare pathogen genome- 
wide data with radiological pathology in M. tuberculosis. 
We identified that MDRTB patients with disease caused by 
a pathogen harbouring the Rv2828c.141 mutation had 30% 
increased risk of more extensive radiological pathology. Those 
MDRTB patients with disease caused by strains carrying the 
rpoC.1040 polymorphism were twice as likely to have more 
extensive radiological disease. Conversely, the rpoB.450 muta-
tion was 20% protective of radiological pathology, although this 
association was not observed to be independent of lineage nor to 
prior TB after additional PCA correction and subanalysis.
The finding that strains with the rifampicin resistance rpoB.
S450L mutation were associated with less widespread pathology 
and those with the rpoC.1040 polymorphism with more wide-
spread pathology supports the notion that rifampicin resis-
tance mediated by the rpoB.450 mutation is associated with a 
fitness cost that is compensated for by secondary mutations in 
rpoC.9 Interestingly, no evidence of a fitness cost as manifest 
by radiological pathology score was found for the katG.315 
mutation that confers isoniazid resistance in M. tuberculosis, 
which may explain why this mutation is often found in multicase 
households.29
The third mutation significantly associated with lung pathology 
(Rv2828c.141) falls in the Rv2828 gene, which is part of a toxin–
antitoxin system together with vapBC22. Patients infected with 
strains carrying the homoplastic Rv2828c.141 mutation had on 
average 30% more severe pathology. The vapB22, vapC22 and 
the Rv2828 genes were all significantly upregulated in drug- 
resistant South African Beijing strains relative to drug susceptible 
control strains, suggesting that the action of these genes is indeed 
important in the survival of drug- resistant TB strains.30 An iden-
tical mutation in Rv2828 at codon position 141 was also selected 
when the cell wall of susceptible TB strains was stressed by a 
novel antituberculous coumarin compound.31 Farhat et al, in a 
global strain collection, identified this gene to be under signifi-
cant positive selection, suggesting that the gene is a site of adap-
tive advantageous evolution.12
It is self- evident that previous TB disease will be associated 
with more widespread pathology and our data also support this. 
It is not clear whether patients coinfected with TB- HIV more 
readily transmit TB or have increased disease severity.32 The 
number of HIV- infected patients in our study was low and the 
difference in disease severity was not found to be statistically 
significant.
The extent of radiological pathology on chest radiograph is 
predictive of smear positivity at 2 months into treatment14; Wells 
and Riley in their seminal studies of TB transmission describe 
bacterial burden as a predictor of infectiousness, while clinicians 
use the extent of parenchymal involvement as well as bacterial 
burden to predict the likely infectiousness of the patient. Under-
standing which polymorphisms are associated with extensive 
pathology may therefore aid clinicians in determining index case 
infectiousness and the likelihood of developing a secondary case 
of disease. Whether these polymorphisms are associated with the 
transmission of MDRTB requires prospective cohort studies of 
contacts exposed to wild type and mutant disease.
This study was strengthened by the use of bacterial whole 
genome sequencing, the ability to make comparison to pretreat-
ment chest radiographs and the availability of potentially 
confounding variables to adjust the findings in the context of 
a multivariable model. However, it is clear that the causes of 
radiological pathology at diagnosis are multifactorial. Although 
‘the delay to diagnosis’ is an unreliable variable to capture with 
often vague symptom start dates, this study is limited by the lack 
of data for this important confounding variable. Similarly, the 
socioeconomic status of the patient is likely to influence both 
the delay to presentation and adherence to prior treatment,33 
making this a variable also likely to be associated with pathology 
on the chest radiograph. For those patients with previous 
TB disease, we did not capture data on the phenotype of the 
previous disease. However, a subanalysis restricted solely to TB 
naïve patients did not alter the principal findings.
The Bland- Altman comparison between observers demon-
strated a 4.7% mean difference in pathology scores and the 
Spearman rank correlation between observers was significant. 
However, there was an increased difference between observers 
at the higher pathology scores. Future studies could improve 
the interobserver agreement by calibrating both observers on a 
training data set or employing AI pattern recognition algorithms 
instead from the outset.
In summary, this study provides a novel and interesting insight 
into the association of bacterial homoplastic polymorphisms 
with the extent of pathology on the chest radiograph following 
infection with M. tuberculosis. With improved statistical power, 
it may be possible to identify a larger set of bacterial genetic 
markers that help predict pathology, disease outcome and trans-
mission. Prospective cohort studies are also warranted to deter-
mine if polymorphisms in the bacterial genome of the index case 
such as these are independently predictive of secondary cases of 
disease and the development of severe radiological pathology 
among close contacts.
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